Pharmaceutical Executive
Outlining one country’s unique price-setting model for novel drugs-and the resulting pre-launch strategies for manufacturers.
Mariana Torgal
Advertisement
Articles by Mariana Torgal
Advertisement
Latest Updated Articles
CMED: The ‘Curupira’ of Brazil’s Pharma MarketFebruary 21st 2017
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5